U.S. markets open in 5 hours
  • S&P Futures

    3,850.75
    +5.75 (+0.15%)
     
  • Dow Futures

    31,106.00
    +10.00 (+0.03%)
     
  • Nasdaq Futures

    13,350.75
    +56.50 (+0.42%)
     
  • Russell 2000 Futures

    2,156.70
    -1.00 (-0.05%)
     
  • Crude Oil

    52.94
    -0.37 (-0.69%)
     
  • Gold

    1,870.40
    +3.90 (+0.21%)
     
  • Silver

    25.99
    +0.22 (+0.87%)
     
  • EUR/USD

    1.2145
    +0.0029 (+0.24%)
     
  • 10-Yr Bond

    1.0900
    0.0000 (0.00%)
     
  • Vix

    21.44
    -1.80 (-7.75%)
     
  • GBP/USD

    1.3742
    +0.0087 (+0.64%)
     
  • USD/JPY

    103.4640
    -0.1060 (-0.10%)
     
  • BTC-USD

    33,169.73
    -332.37 (-0.99%)
     
  • CMC Crypto 200

    657.48
    -43.14 (-6.16%)
     
  • FTSE 100

    6,738.12
    -2.27 (-0.03%)
     
  • Nikkei 225

    28,756.86
    +233.60 (+0.82%)
     

Gilead Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021

·1 min read

Webcast Available Through Gilead Corporate Website

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Daniel O’Day, Gilead’s Chairman and Chief Executive Officer, will provide an overview of the company at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11 at 12:40 p.m. Pacific Time.

The live webcast can be accessed at the company’s Investors page at http://investors.gilead.com. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information about Gilead, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201221005099/en/

Contacts

Monica Tellado, Investors
(650) 522-5132